Free Trial Information
BioCentury | Nov 8, 2010
Company News

HepaLife Technologies management update

HepaLife Technologies Inc. (OTCBB:HPLF), New York, N.Y. Business: Hepatic, Infectious, Diagnostic Hired: Matt Harriton as CEO of HepaLife's Alliqua BioMedical Inc. subsidiary, formerly CEO of AquaMed Technologies Inc. WIR Staff...
Read More
BioCentury | Jul 26, 2010
Company News

AquaMed Technologies Inc., HepaLife Technologies deal

...liver failure. Palladium Capital Advisors LLC advised HepaLife. AquaMed Technologies Inc. , West Chicago, Ill. HepaLife Technologies Inc....
Read More
BioCentury | Oct 6, 2008
Company News

HepaLife Technologies, U.S. Department of Agriculture deal

...host systems for viral and protozoan agents such as malaria (see BioCentury, Nov. 12, 2007). HepaLife Technologies Inc....
Read More
BioCentury | Nov 12, 2007
Company News

HepaLife Technologies, U.S. Department of Agriculture deal

...and commercialize artificial liver devices and in-vitro toxicological testing platforms. Further terms were not disclosed. HepaLife Technologies Inc....
Read More
BioCentury | Jul 17, 2006
Company News

HepaLife Technologies, Michigan State University deal

...use in developing assays and producing vaccines. The university is eligible for milestones and royalties. HepaLife Technologies Inc....
Read More
Items per page:
1 - 5 of 5
BioCentury | Nov 8, 2010
Company News

HepaLife Technologies management update

HepaLife Technologies Inc. (OTCBB:HPLF), New York, N.Y. Business: Hepatic, Infectious, Diagnostic Hired: Matt Harriton as CEO of HepaLife's Alliqua BioMedical Inc. subsidiary, formerly CEO of AquaMed Technologies Inc. WIR Staff...
Read More
BioCentury | Jul 26, 2010
Company News

AquaMed Technologies Inc., HepaLife Technologies deal

...liver failure. Palladium Capital Advisors LLC advised HepaLife. AquaMed Technologies Inc. , West Chicago, Ill. HepaLife Technologies Inc....
Read More
BioCentury | Oct 6, 2008
Company News

HepaLife Technologies, U.S. Department of Agriculture deal

...host systems for viral and protozoan agents such as malaria (see BioCentury, Nov. 12, 2007). HepaLife Technologies Inc....
Read More
BioCentury | Nov 12, 2007
Company News

HepaLife Technologies, U.S. Department of Agriculture deal

...and commercialize artificial liver devices and in-vitro toxicological testing platforms. Further terms were not disclosed. HepaLife Technologies Inc....
Read More
BioCentury | Jul 17, 2006
Company News

HepaLife Technologies, Michigan State University deal

...use in developing assays and producing vaccines. The university is eligible for milestones and royalties. HepaLife Technologies Inc....
Read More
Items per page:
1 - 5 of 5